blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2120987

EP2120987 - TREATING STROKE AND OTHER DISEASES WITHOUT INHIBITING N-TYPE CALCIUM CHANNELS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.11.2014
Database last updated on 02.09.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): LU, TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
NoNO Inc.
88 Strath Avenue
Toronto ON M8X 1R5 / CA
[2012/26]
Former [2012/19]For all designated states
NoNO, Inc.
88 Strath Avenue
Toronto ON M8X 1R5 / CA
Former [2009/48]For all designated states
Arbor Vita Corporation
772 Lucerne Drive
Sunnyvale, CA 94085 / US
For all designated states
Nono Inc.
88 Strath Avenue
Toronto, ON M8X 1R5 / CA
Inventor(s)01 / BELMARES, Michael, P.
772 Lucerne Drive
Sunnyvale, CA 94085 / US
02 / GARMAN, Jonathan, David
772 Lucerne Drive
Sunnyvale, CA 94085 / US
03 / LU, Peter, S.
772 Lucerne Drive
Sunnyvale, CA 94085 / US
04 / SALTER, Michael, W.
88 Strath Avenue
Toronto, Ontario, M8X 1R5 / CA
05 / TYMIANSKI, Michael
88 Strath Avenue
Toronto, Ontario, M8X 1R5 / CA
 [2009/48]
Representative(s)Green, Mark Charles, et al
Murgitroyd & Company London
Euston House
24 Eversholt Street
London NW1 1AD / GB
[N/P]
Former [2014/03]Green, Mark Charles, et al
Urquhart-Dykes & Lord LLP
3rd Floor
33 Glasshouse Street
London W1B 5DG / GB
Former [2009/48]Green, Mark Charles, et al
Urquhart-Dykes & Lord LLP 30 Welbeck Street
London W1G 8ER / GB
Application number, filing date08726313.329.02.2008
[2009/48]
WO2008US02754
Priority number, dateUS20070904507P02.03.2007         Original published format: US 904507 P
[2009/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008109010
Date:12.09.2008
Language:EN
[2008/37]
Type: A1 Application with search report 
No.:EP2120987
Date:25.11.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.2008 takes the place of the publication of the European patent application.
[2009/48]
Type: B1 Patent specification 
No.:EP2120987
Date:15.01.2014
Language:EN
[2014/03]
Search report(s)International search report - published on:US12.09.2008
(Supplementary) European search report - dispatched on:EP16.07.2010
ClassificationIPC:A61K38/00, A61K38/04, A61K38/10, A61K38/16, C07K14/435
[2009/48]
CPC:
C07K14/70571 (EP,US); C07K7/06 (US); A61K47/645 (EP,US);
A61P25/00 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); A61K38/00 (EP,US); C07K2319/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/48]
TitleGerman:BEHANDLUNG VON SCHLAGANFALL UND ANDEREN KRANKHEITEN OHNE HEMMUNG VON N-CALCIUM-KANÄLEN[2009/48]
English:TREATING STROKE AND OTHER DISEASES WITHOUT INHIBITING N-TYPE CALCIUM CHANNELS[2009/48]
French:TRAITEMENT DES INCIDENTS CÉRÉBROVASCULAIRES ET D'AUTRES MALADIES SANS INHIBITION DES CANAUX CALCIUM DE TYPE N[2009/48]
Entry into regional phase03.09.2009National basic fee paid 
03.09.2009Search fee paid 
03.09.2009Designation fee(s) paid 
03.09.2009Examination fee paid 
Examination procedure03.09.2009Examination requested  [2009/48]
09.02.2011Amendment by applicant (claims and/or description)
28.11.2011Despatch of a communication from the examining division (Time limit: M04)
28.02.2012Reply to a communication from the examining division
14.12.2012Despatch of a communication from the examining division (Time limit: M06)
17.05.2013Reply to a communication from the examining division
15.07.2013Communication of intention to grant the patent
23.10.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
23.10.2013Fee for grant paid
23.10.2013Fee for publishing/printing paid
22.11.2013Communication of intention to grant the patent
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.11.2011
Opposition(s)16.10.2014No opposition filed within time limit [2014/52]
Fees paidRenewal fee
08.02.2010Renewal fee patent year 03
15.02.2011Renewal fee patent year 04
15.02.2012Renewal fee patent year 05
12.02.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.02.2008
AT15.01.2014
BE15.01.2014
BG15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
MT15.01.2014
PL15.01.2014
RO15.01.2014
SI15.01.2014
SK15.01.2014
TR15.01.2014
LU28.02.2014
NO15.04.2014
GR16.04.2014
IS15.05.2014
PT15.05.2014
[2016/33]
Former [2016/32]HU29.02.2008
AT15.01.2014
BE15.01.2014
BG15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
MT15.01.2014
PL15.01.2014
RO15.01.2014
SI15.01.2014
SK15.01.2014
NO15.04.2014
GR16.04.2014
IS15.05.2014
PT15.05.2014
Former [2016/28]AT15.01.2014
BE15.01.2014
BG15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
MT15.01.2014
PL15.01.2014
RO15.01.2014
SI15.01.2014
SK15.01.2014
NO15.04.2014
GR16.04.2014
IS15.05.2014
PT15.05.2014
Former [2016/25]AT15.01.2014
BE15.01.2014
BG15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
MT15.01.2014
PL15.01.2014
RO15.01.2014
SI15.01.2014
SK15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2016/12]AT15.01.2014
BE15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
MT15.01.2014
PL15.01.2014
RO15.01.2014
SI15.01.2014
SK15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2015/24]AT15.01.2014
BE15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
PL15.01.2014
RO15.01.2014
SI15.01.2014
SK15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2014/50]AT15.01.2014
BE15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
PL15.01.2014
RO15.01.2014
SK15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2014/49]AT15.01.2014
BE15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
RO15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2014/48]AT15.01.2014
BE15.01.2014
CY15.01.2014
CZ15.01.2014
EE15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2014/46]AT15.01.2014
BE15.01.2014
CY15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
MC15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2014/41]AT15.01.2014
BE15.01.2014
CY15.01.2014
FI15.01.2014
HR15.01.2014
LT15.01.2014
LV15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2014/37]AT15.01.2014
CY15.01.2014
FI15.01.2014
LT15.01.2014
NO15.04.2014
IS15.05.2014
PT15.05.2014
Former [2014/36]LT15.01.2014
NO15.04.2014
IS15.05.2014
Documents cited:Search[A]WO0149832  (ARTEMIS PHARMACEUTICALS GMBH [DE]) [A] 1-15 * claim 5; sequence 19 *;
 [X]WO03076561  (ARTEMIS PHARMACEUTICALS GMBH [DE], et al) [X] 11,13-15 * claims 1-11; sequence 41 *;
 [X]WO2005035562  (YAMANAKA SHINYA [JP], et al) [X] 11,13-15 * sequences 10, 14 *;
 [A]WO2006084179  (CHIRON CORP [US], et al) [A] 1-15 * figure 7 *;
 [AP]  - JOURNAL OF NEUROSCIENCE, (200709), vol. 27, no. 37, ISSN 0270-6474, pages 9901 - 9915, XP002581414 [AP] 1-15

DOI:   http://dx.doi.org/10.1523/jneurosci.1464-07.2007
 [A]  - HSU CHUN ET AL, "Perturbing NMDA receptor - PSD-95 protein interactions prevents selective loss of nitric oxide synthase (NOS) containing neuron in rat gastric myenteric plexus", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200604), Database accession no. PREV200600502290, XP009133060 [A] 1-15 * abstract *
    [ ] - GASTROENTEROLOGY, DIGESTIVE DISEASE WEEK MEETING/107TH ANNUAL MEETING OF THE AMERICAN-GASTROENTEROLOGICAL-ASSOCIATION; LOS ANGELES, CA, USA; MAY 19 24, 2006, (200604), vol. 130, no. 4, Suppl. 2, ISSN 0016-5085, page A30
 [A]  - AARTS MICHELLE ET AL, "Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US LNKD- DOI:10.1126/SCIENCE.1072873, (20021025), vol. 298, no. 5594, ISSN 0036-8075, pages 846 - 850, XP002476284 [A] 1-15

DOI:   http://dx.doi.org/10.1126/science.1072873
 [A]  - LIU Y ET AL, "UNCOUPLING NMDA RECEPTOR - PSD - 95 PROTEIN INTERACTIONS REDUCES INFARCTION IN FOCAL CEREBRAL ISCHEMIA IN RATS.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2002), Database accession no. PREV200300283348, XP009133058 [A] 1-15 * abstract *
    [ ] - SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, 32ND ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; ORLANDO, FLORIDA, USA; NOVEMBER 02-07, 2002, (2002), vol. 2002, pages Abstract No. 245.3 URL - http://sf
 [A]  - AARTS M M ET AL, "UNCOUPLING OF NMDAR SIGNALING FROM NEUROTOXICITY BY TAT - FUSION PEPTIDES.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2002), Database accession no. PREV200300283347, XP009133059 [A] 1-15 * abstract *
    [ ] - SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, 32ND ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; ORLANDO, FLORIDA, USA; NOVEMBER 02-07, 2002, (2002), vol. 2002, pages Abstract No. 245.2 URL - http://sf
International search[A]  - TYAGI ET AL., "Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans", J. BIOLOGICAL CHEMISTRY, (20010202), vol. 276, no. 5, pages 3254 - 3261, XP008116001

DOI:   http://dx.doi.org/10.1074/jbc.M006701200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.